Cardio Diagnostics Holdings, INC Form 4 insider transactions

Cardio Diagnostics' Chief Technology Officer, Timur Dogan, amended a previous Form 4 filing to reflect a stock purchase made on September 6, 2024.

Cardio Diagnostics CEO Meeshanthini Dogan reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Meeshanthini Dogan, CEO of Cardio Diagnostics Holdings, Inc., purchased 68,965 shares of common stock at $0.29 per share on September 6, 2024, increasing her total holdings.

Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Robert Philibert, Chief Medical Officer and Director of Cardio Diagnostics Holdings, recently acquired additional shares of common stock through indirect ownership.

Meeshanthini Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc., reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Meeshanthini Dogan, CEO of Cardio Diagnostics Holdings, Inc., reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Director Oded Levy reports acquiring stock options in Cardio Diagnostics Holdings, Inc. on June 30, 2024.

Director Stanley Lau reports acquisition of stock options in Cardio Diagnostics Holdings, Inc. on June 30, 2024.

Director James Intrater acquired 7,575 stock options in Cardio Diagnostics Holdings, Inc. on June 30, 2024.

Paul Frederick Burton, a director at Cardio Diagnostics Holdings, acquired 7,575 stock options on June 30, 2024, exercisable at $0.55.

Paul Frederick Burton, a director at Cardio Diagnostics Holdings, Inc., settled restricted stock units (RSUs) for common stock on March 31, 2024.

Director Stanley Lau settled restricted stock units for Cardio Diagnostics Holdings, Inc. on March 31, 2024, resulting in the acquisition of 8,803 shares of common stock.

Director James Intrater settled restricted stock units (RSUs) for Cardio Diagnostics Holdings, Inc. on March 31, 2024, resulting in the acquisition of 8,803 shares of common stock.

Director Oded Levy settled vested restricted stock units (RSUs) for shares of Cardio Diagnostics Holdings, Inc. common stock on March 31, 2024.